Core Laboratories filed an amended Form 8-K to correct financial information in its earnings release for the quarter and year ended Dec. 31, 2025. The company said estimated income tax expense for that period was understated by 4.2 million, reducing net income by the same amount. It also reported immaterial balance sheet corrections as of Dec. 31, 2024, including a 4.7 million misclassification between income taxes receivable and deferred tax liabilities. Core Laboratories also recorded a 5.6 million write-off of unrecoverable income taxes receivable, reflected as an adjustment to beginning retained earnings. The company said the tax expense correction did not change consolidated revenue, operating income, income before tax, or cash from operations as previously presented.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-109251), on March 17, 2026, and is solely responsible for the information contained therein.
Comments